Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
7.59
-0.19 (-2.44%)
At close: Dec 5, 2025, 4:00 PM EST
7.57
-0.02 (-0.26%)
After-hours: Dec 5, 2025, 7:59 PM EST
Teladoc Health Revenue
Teladoc Health had revenue of $626.44M in the quarter ending September 30, 2025, a decrease of -2.20%. This brings the company's revenue in the last twelve months to $2.53B, down -2.37% year-over-year. In the year 2024, Teladoc Health had annual revenue of $2.57B, down -1.26%.
Revenue (ttm)
$2.53B
Revenue Growth
-2.37%
P/S Ratio
0.53
Revenue / Employee
$459,673
Employees
5,500
Market Cap
1.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
| Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
| Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
| Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
| Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TDOC News
- 3 days ago - Teladoc Health, Inc. (TDOC) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 9 days ago - Teladoc Health to Participate in Upcoming Investor Conference - GlobeNewsWire
- 16 days ago - Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? - The Motley Fool
- 17 days ago - TytoCare Integrates With Teladoc Health to Augment Virtual Primary and Urgent Care - PRNewsWire
- 22 days ago - Teladoc Health: Fading Hope - Seeking Alpha
- 4 weeks ago - Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 - GlobeNewsWire
- 4 weeks ago - Why Teladoc Stock Zoomed Almost 12% Higher in October - The Motley Fool
- 4 weeks ago - Is This Beaten-Down Stock Finally on the Road to Recovery? - The Motley Fool